Literature DB >> 17479228

Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.

Baisakhi Raychaudhuri1, Yulong Han, Tao Lu, Michael A Vogelbaum.   

Abstract

Several recent studies have shown that aberrant constitutive activation of nuclear factor kappaB (NF-kappaB) is present in a variety of cancers including gliomas. NF-kappaB is known to play important roles in the physiological regulation of diverse cellular processes such as inflammation, growth and immunity. In contrast, aberrant activation of this latent transcription factor promotes cancer cell migration, invasion and resistance to chemotherapy. Here we show by electro-mobility shift assay (EMSA) and immuno-staining that constitutive NF-kappaB activation is present in various malignant glioma cell lines as well as in primary cultures derived from tumor tissue. This activation was not serum dependent and it led to high IL-8 gene transcription and protein production. Over-expression of an I-kappaB super-repressor (I-kappaB SR) transgene completely blocked constitutive NF-kappaB activation, nuclear localization and transcription of some but not all NF-kappaB regulated genes indicating that NF-kappaB signaling in glioma cells is I-kappaB dependent. Surprisingly, over-expression of IkappaBSR did not have any effect on the transcription levels of anti-apoptotic genes in these glioma cultures and cell lines. Down-regulation of NF-kappaB activation reduced invasion of glioma cells through matrigel. Collectively these data suggest that aberrant constitutive activation of NF-kappaB in glioblastoma cells promotes their invasive phenotype. Interruption of this aberrant NF-kappaB activity may help reduce the spread of this infiltrative tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17479228     DOI: 10.1007/s11060-007-9390-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  41 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma.

Authors:  Shoichi Nagai; Kazuo Washiyama; Masanori Kurimoto; Akira Takaku; Shunro Endo; Toshiro Kumanishi
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

Review 3.  The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.

Authors:  Daniel J Brat; Anita C Bellail; Erwin G Van Meir
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 4.  Gelatinase-mediated migration and invasion of cancer cells.

Authors:  Mikael Björklund; Erkki Koivunen
Journal:  Biochim Biophys Acta       Date:  2005-04-12

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells.

Authors:  U Kordes; D Krappmann; V Heissmeyer; W D Ludwig; C Scheidereit
Journal:  Leukemia       Date:  2000-03       Impact factor: 11.528

7.  Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.

Authors:  D C Duffey; Z Chen; G Dong; F G Ondrey; J S Wolf; K Brown; U Siebenlist; C Van Waes
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

Review 8.  Molecular mechanisms of glioma invasiveness: the role of proteases.

Authors:  Jasti S Rao
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

Review 9.  Surgical treatment of metastatic brain tumors.

Authors:  R Sawaya; B L Ligon; A K Bindal; R K Bindal; K R Hess
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

10.  NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?

Authors:  William R Coward; Yoshimichi Okayama; Hironori Sagara; Susan J Wilson; Stephen T Holgate; Martin K Church
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

View more
  52 in total

1.  NFKBIA deletion in glioblastomas.

Authors:  Markus Bredel; Denise M Scholtens; Ajay K Yadav; Angel A Alvarez; Jaclyn J Renfrow; James P Chandler; Irene L Y Yu; Maria S Carro; Fangping Dai; Michael J Tagge; Roberto Ferrarese; Claudia Bredel; Heidi S Phillips; Paul J Lukac; Pierre A Robe; Astrid Weyerbrock; Hannes Vogel; Steven Dubner; Bret Mobley; Xiaolin He; Adrienne C Scheck; Branimir I Sikic; Kenneth D Aldape; Arnab Chakravarti; Griffith R Harsh
Journal:  N Engl J Med       Date:  2010-12-22       Impact factor: 91.245

2.  Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling.

Authors:  Alfeu Zanotto-Filho; Elizandra Braganhol; Ana Maria Oliveira Battastini; José Cláudio Fonseca Moreira
Journal:  Invest New Drugs       Date:  2012-02-28       Impact factor: 3.850

3.  Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma.

Authors:  David J Voce; Giovanna M Bernal; Longtao Wu; Clayton D Crawley; Wei Zhang; Nassir M Mansour; Kirk E Cahill; Szymon J Szymura; Abhineet Uppal; David R Raleigh; Ruben Spretz; Luis Nunez; Gustavo Larsen; Nikolai N Khodarev; Ralph R Weichselbaum; Bakhtiar Yamini
Journal:  Cancer Res       Date:  2019-04-02       Impact factor: 12.701

4.  Dissecting Glioma Invasiveness in a 3D-Organotypic Model.

Authors:  Paolo Codega; Ingo K Mellinghoff
Journal:  Trends Mol Med       Date:  2017-08-03       Impact factor: 11.951

5.  IL-8 is a mediator of NF-κB induced invasion by gliomas.

Authors:  Baisakhi Raychaudhuri; Michael A Vogelbaum
Journal:  J Neurooncol       Date:  2010-06-25       Impact factor: 4.130

6.  A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.

Authors:  Toshimasa Akazawa; Shawn G Kwatra; Laura E Goldsmith; Mark D Richardson; Elizabeth A Cox; John H Sampson; Madan M Kwatra
Journal:  J Neurochem       Date:  2009-03-11       Impact factor: 5.372

7.  Astrocyte elevated gene-1: a novel target for human glioma therapy.

Authors:  Luni Emdad; Devanand Sarkar; Seok-Geun Lee; Zhao Zhong Su; Byoung Kwon Yoo; Rupesh Dash; Adly Yacoub; Christine E Fuller; Khalid Shah; Paul Dent; Jeffrey N Bruce; Paul B Fisher
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

8.  Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.

Authors:  Udi Vazana; Ronel Veksler; Gaby S Pell; Ofer Prager; Michael Fassler; Yoash Chassidim; Yiftach Roth; Hamutal Shahar; Abraham Zangen; Ruggero Raccah; Emanuela Onesti; Marco Ceccanti; Claudio Colonnese; Antonio Santoro; Maurizio Salvati; Alessandro D'Elia; Valter Nucciarelli; Maurizio Inghilleri; Alon Friedman
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

9.  Bortezomib downregulates MGMT expression in T98G glioblastoma cells.

Authors:  Panagiotis J Vlachostergios; Eleana Hatzidaki; Nikolaos E Stathakis; George K Koukoulis; Christos N Papandreou
Journal:  Cell Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.046

10.  Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.

Authors:  Anastasia Murat; Eugenia Migliavacca; S Farzana Hussain; Amy B Heimberger; Isabelle Desbaillets; Marie-France Hamou; Curzio Rüegg; Roger Stupp; Mauro Delorenzi; Monika E Hegi
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.